Dutch Injunction Constrains Keytruda SC Across Eight Markets
A specialized Dutch court found that Merck’s subcutaneous pembrolizumab product infringes Halozyme’s MDASE patent EP 2,797,622 and ordered MSD BV to stop specified manufacturing, distribution, marketing, use, import, and stocking activities tied to Keytruda…
